Multiple Sclerosis Clinical Trials
Find clinical trials for multiple sclerosis. Search for multiple sclerosis clinical trials in different cities and states across the United States.
High Intensity Functional TrainingHigh Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners
Sponsor:
Arkansas Colleges of Health Education
Location:
Code:
NCT05951985
Conditions
Neurologic Disorder
Parkinson Disease
Spinal Cord Injuries
Spina Bifida
Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
HIFT
Brain ImagingMicroglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease
Sponsor:
Brigham and Women's Hospital
Location:
Code:
NCT02649985
Conditions
Multiple Sclerosis
Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
[F-18]PBR06
[C-11]PBR28
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Functional RecoveryA Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
Sponsor:
Kessler Foundation
Location:
Code:
NCT06197685
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
The Kessler Foundation modified Story Memory Technique® (KF-mSMT®)
Aerobic Exercise Training (AET) plus Virtual Reality (IDEAL)
Stretching and Toning (S/T)
Ozanimod vs. FingolimodStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Sponsor:
Celgene
Location:
Code:
NCT06408259
Conditions
Multiple Sclerosis, Relapsing-Remitting
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Ozanimod
Fingolimod
Placebo
Observational StudyAn Individualized-health eLibrary App for People With Multiple Sclerosis
Sponsor:
University of Illinois at Urbana-Champaign
Location:
Code:
NCT05124600
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SavvyHealth
NeuroVax™A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Sponsor:
Immune Response BioPharma, Inc.
Location:
Code:
NCT02057159
Conditions
Secondary Progress Multiple Sclerosis
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
NeuroVax
IFA Placebo
HOBSCOTCHHOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)
Sponsor:
Dartmouth-Hitchcock Medical Center
Location:
Code:
NCT06145737
Conditions
Multiple Sclerosis
Cognitive Dysfunction
Memory Disorders
Eligibility Criteria
Sex: All
Age: 20 - 65
Healthy Volunteers: Not accepted
Interventions
HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH)
What are multiple sclerosis (MS) clinical trials?
Multiple sclerosis (MS) clinical trials are research studies that test new ways to treat, manage, or prevent MS. These trials are essential for developing new medications, therapies, and strategies to improve the quality of life for individuals living with MS. They range from early-stage research, testing the safety and efficacy of new treatments, to later-stage trials that compare new treatments to current standards.
The importance of clinical trials in MS research
Clinical trials are fundamental to MS research as they provide the scientific basis for developing new treatments and understanding the disease better. Through these trials, researchers can evaluate the effectiveness of new drugs, therapies, and management strategies, ensuring that only the most effective treatments are approved for general use. Clinical trials also help in identifying the causes of MS and factors that influence disease progression.
Types of multiple sclerosis clinical trials
Multiple sclerosis (MS) clinical trials encompass a range of studies, each targeting different aspects of this neurological condition. They range from exploring new medications and therapies aimed at managing symptoms and altering the disease's course, to prevention strategies and rehabilitation methods to enhance the quality of life for those affected.
Treatment trials
Treatment trials in MS focus on finding new medications or treatment strategies to manage the symptoms of MS. These include trials for drugs that can effectively manage symptoms of MS, reduce the frequency and severity of relapses, and slow the progression of the disease.
Prevention trials to delay or prevent MS progression
Prevention trials aim to identify strategies that could prevent MS or delay its progression in individuals who are at high risk or in the early stages of the disease. These studies might involve lifestyle changes, medications, or other interventions that could potentially prevent the onset or reduce the progression of MS.
Rehabilitation trials
Rehabilitation trials research ways to improve daily functioning and quality of life for those diagnosed with MS. These trials might test physical therapy programs, cognitive rehabilitation techniques, or novel assistive technologies designed to help manage the symptoms of MS.
Trials for emerging therapies
These trials explore the potential of new and emerging therapies in MS treatment, such as stem cell therapy, neuroprotective strategies, and novel immunotherapies. The goal is to find breakthrough treatments that can significantly alter the course of MS.
Who can participate in MS clinical trials?
Eligibility for MS clinical trials varies depending on the study's focus. Generally, these trials are open to individuals who have been diagnosed with MS, though specific criteria like the type of MS, the stage of the disease, and overall health will vary. Some trials may also be open to healthy volunteers without MS for preventative studies.
What to expect when joining an MS clinical trial
When joining an MS clinical trial, participants can expect to go through a detailed consent process, where they will be informed about the purpose of the study, the procedures involved, potential risks and benefits, and their rights as participants. Participants will undergo initial evaluations and be closely monitored throughout the study for any changes in their condition. Regular follow-ups and assessments are usually part of the process to ensure the effectiveness of the treatment being studied.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial for multiple sclerosis
Enrolling in an MS clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.